Miles Capital Inc. trimmed its stake in HCA Healthcare Inc (NYSE:HCA) by 4.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,491 shares of the company’s stock after selling 343 shares during the period. HCA Healthcare accounts for about 0.9% of Miles Capital Inc.’s investment portfolio, making the stock its 23rd biggest holding. Miles Capital Inc.’s holdings in HCA Healthcare were worth $1,107,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Nuveen Asset Management LLC lifted its holdings in HCA Healthcare by 1,105.9% in the second quarter. Nuveen Asset Management LLC now owns 3,165,181 shares of the company’s stock worth $427,837,000 after buying an additional 2,902,715 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of HCA Healthcare by 9.5% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 15,906,139 shares of the company’s stock valued at $2,150,033,000 after buying an additional 1,375,021 shares in the last quarter. Schroder Investment Management Group boosted its holdings in shares of HCA Healthcare by 215.7% during the 2nd quarter. Schroder Investment Management Group now owns 1,328,422 shares of the company’s stock valued at $179,562,000 after buying an additional 907,658 shares in the last quarter. Assenagon Asset Management S.A. boosted its holdings in shares of HCA Healthcare by 7,356.0% during the 4th quarter. Assenagon Asset Management S.A. now owns 710,105 shares of the company’s stock valued at $104,961,000 after buying an additional 700,581 shares in the last quarter. Finally, Redmile Group LLC purchased a new stake in shares of HCA Healthcare in the 3rd quarter worth about $28,359,000. 69.33% of the stock is currently owned by hedge funds and other institutional investors.
HCA stock traded down $1.02 during trading on Tuesday, hitting $147.38. 174,254 shares of the stock traded hands, compared to its average volume of 911,399. The stock has a market cap of $50.33 billion, a price-to-earnings ratio of 14.75, a price-to-earnings-growth ratio of 1.13 and a beta of 0.92. HCA Healthcare Inc has a 1 year low of $110.31 and a 1 year high of $150.17. The firm’s 50 day moving average is $146.17 and its two-hundred day moving average is $133.63.
HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, October 29th. The company reported $2.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.13 by $0.10. The business had revenue of $12.69 billion during the quarter, compared to analysts’ expectations of $12.48 billion. HCA Healthcare had a net margin of 6.98% and a negative return on equity of 173.49%. The business’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same period in the previous year, the company earned $2.16 earnings per share. As a group, equities research analysts anticipate that HCA Healthcare Inc will post 10.53 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Monday, December 2nd were given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.09%. The ex-dividend date of this dividend was Friday, November 29th. HCA Healthcare’s dividend payout ratio (DPR) is currently 16.38%.
A number of research analysts recently issued reports on HCA shares. Barclays lifted their price target on shares of HCA Healthcare from $145.00 to $155.00 and gave the company an “overweight” rating in a research report on Wednesday, October 30th. JPMorgan Chase & Co. boosted their price objective on shares of HCA Healthcare from $157.00 to $186.00 and gave the stock an “overweight” rating in a research note on Friday, December 20th. Deutsche Bank started coverage on shares of HCA Healthcare in a report on Friday, January 3rd. They issued a “buy” rating and a $140.00 price objective on the stock. ValuEngine raised shares of HCA Healthcare from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, Bank of America upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating in a report on Friday, December 6th. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $156.07.
In related news, SVP Deborah M. Reiner sold 749 shares of HCA Healthcare stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $136.67, for a total value of $102,365.83. Following the completion of the sale, the senior vice president now directly owns 8,237 shares in the company, valued at approximately $1,125,750.79. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Jon M. Foster sold 19,477 shares of HCA Healthcare stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $132.35, for a total value of $2,577,780.95. Following the completion of the sale, the insider now owns 10,015 shares of the company’s stock, valued at $1,325,485.25. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 48,511 shares of company stock valued at $6,592,095. 2.70% of the stock is owned by company insiders.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Read More: Cash Flow
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.